The FDA has not required that Anemagen™ OB Soft Gelatin Capsules or New Formulation Chromagen OB™(Savage Labs) be approved for therapeutic equivalence or rated for therapeutic equivalence. Anemagen™ OB Soft Gelatin Capsules is not the subject of an FDA approval. Even when products are labeled as containing the same active ingredients, they may be subject to different potency specifications and may contain different inactive ingredients. State law governs the substitution of prescription pharmaceuticals.
For further information about this product please see our product insert sheet (PDF download).
Product Insert Sheet
If you have additional product questions,
please contact ETHEX. For product
legal information please see our disclaimer.
Images shown are not actual size.
PDFs documents can be read using the
Adobe Acrobat
Reader, a free download.
